Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Derivative Liabilities - Fair Value of Derivative Liability (Details)

v3.23.1
Note 8 - Derivative Liabilities - Fair Value of Derivative Liability (Details) - Derivative Financial Instruments, Liabilities [Member] - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Series G Warrant [Member]    
Beginning balance at September 30, 2022 $ 748,275  
Exchange of warrants into common stock (13,948)  
Adjustments to estimated fair value (734,327)  
Ending balance at March 31, 2023 0  
Series G Warrant [Member] | Fair Value, Inputs, Level 3 [Member]    
Beginning balance at September 30, 2022   $ 748,275
Issuances   0
Adjustments to estimated fair value   0
Ending balance at March 31, 2023   748,275
Expiration of derivative liability   0
Series F Warrant [Member] | Fair Value, Inputs, Level 3 [Member]    
Beginning balance at September 30, 2022   1,000,000
Issuances   0
Adjustments to estimated fair value   0
Ending balance at March 31, 2023   0
Expiration of derivative liability   (1,000,000)
Series H Warrant [Member]    
Beginning balance at September 30, 2022 459,200  
Exchange of warrants into common stock (35,330)  
Adjustments to estimated fair value (423,870)  
Ending balance at March 31, 2023 $ 0  
Series H Warrant [Member] | Fair Value, Inputs, Level 3 [Member]    
Beginning balance at September 30, 2022   459,200
Issuances   0
Adjustments to estimated fair value   0
Ending balance at March 31, 2023   459,200
Expiration of derivative liability   $ 0